Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 19 days ago
Share
A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease
120 patients around the world
Available in
Argentina, United States
Hoffmann-La Roche
2
Research sites
120
Patients around the world
This study is for people with
Thyroid Disease
Thyroid Eye Disease
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Instituto Oftalmológico de Buenos Aires / Oftalmos
Recruiting
View site
Av. Córdoba 1830, CABA, Buenos Aires
Buenos Aires Mácula S.A.
Recruiting
View site
ARENALES 981, Piso:4 / 1061, CIUDAD AUTONOMA BUENOS AIRES
See details
Contact us
Contact us
Sponsor
Hoffmann-La Roche
Conditions
Thyroid Eye Disease
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05987423
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent